Hellstrom I - Search Results

1

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma.

McIntosh MW, Drescher C, Karlan B, Scholler N, Urban N, Hellstrom KE, Hellstrom I. McIntosh MW, et al. Among authors: hellstrom i, hellstrom ke. Gynecol Oncol. 2004 Oct;95(1):9-15. doi: 10.1016/j.ygyno.2004.07.039. Gynecol Oncol. 2004. PMID: 15385104 Free PMC article.

2

Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125.

Schummer M, Drescher C, Forrest R, Gough S, Thorpe J, Hellström I, Hellström KE, Urban N. Schummer M, et al. Among authors: hellstrom i, hellstrom ke. Gynecol Oncol. 2012 Apr;125(1):65-9. doi: 10.1016/j.ygyno.2011.11.050. Epub 2011 Dec 7. Gynecol Oncol. 2012. PMID: 22155417 Free PMC article. Clinical Trial.

3

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma.

Scholler N, Fu N, Yang Y, Ye Z, Goodman GE, Hellström KE, Hellström I. Scholler N, et al. Among authors: hellstrom i, hellstrom ke. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11531-6. doi: 10.1073/pnas.96.20.11531. Proc Natl Acad Sci U S A. 1999. PMID: 10500211 Free PMC article.

4

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Hellström I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellström KE. Hellström I, et al. Among authors: hellstrom ke. Cancer Res. 2003 Jul 1;63(13):3695-700. Cancer Res. 2003. PMID: 12839961

5

SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other.

Hellstrom I, Hellstrom KE. Hellstrom I, et al. Among authors: hellstrom ke. Adv Exp Med Biol. 2008;622:15-21. doi: 10.1007/978-0-387-68969-2_2. Adv Exp Med Biol. 2008. PMID: 18546615 Review.

6

Anti-mesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patients.

Hellstrom I, Friedman E, Verch T, Yang Y, Korach J, Jaffar J, Swisher E, Zhang B, Ben-Baruch G, Tan MC, Goedegebuure P, Hellstrom KE. Hellstrom I, et al. Among authors: hellstrom ke. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1520-6. doi: 10.1158/1055-9965.EPI-08-0039. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559570

7

fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.

Hellstrom I, Hellstrom KE. Hellstrom I, et al. Among authors: hellstrom ke. Expert Opin Med Diagn. 2011 May 1;5(3):227-240. doi: 10.1517/17530059.2011.559459. Expert Opin Med Diagn. 2011. PMID: 21643459 Free PMC article.

8

Elafin selectively regulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis.

Wei H, Hellström KE, Hellström I. Wei H, et al. Among authors: hellstrom i, hellstrom ke. Gynecol Oncol. 2012 Jun;125(3):727-33. doi: 10.1016/j.ygyno.2012.03.018. Epub 2012 Mar 16. Gynecol Oncol. 2012. PMID: 22430613 Free PMC article.

9

Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.

Feng Q, Wei H, Morihara J, Stern J, Yu M, Kiviat N, Hellstrom I, Hellstrom KE. Feng Q, et al. Among authors: hellstrom i, hellstrom ke. Gynecol Oncol. 2012 Nov;127(2):412-9. doi: 10.1016/j.ygyno.2012.07.098. Epub 2012 Jul 22. Gynecol Oncol. 2012. PMID: 22828962 Free PMC article.

10

Anti-HE4 antibodies in infertile women and women with ovarian cancer.

Hellstrom I, Swisher E, Hellstrom KE, Yip YY, Agnew K, Luborsky JL. Hellstrom I, et al. Among authors: hellstrom ke. Gynecol Oncol. 2013 Sep;130(3):629-33. doi: 10.1016/j.ygyno.2013.05.028. Epub 2013 May 28. Gynecol Oncol. 2013. PMID: 23727327 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters